Protective Effects of Japanese Black Vinegar “Kurozu” and Its Sediment “Kurozu Moromimatsu” on Dextran Sulfate Sodium-induced Experimental Colitis by Toru Shizuma et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
8 
Protective Effects of Japanese 
 Black Vinegar “Kurozu” and Its Sediment 
“Kurozu Moromimatsu” on Dextran Sulfate 
Sodium-induced Experimental Colitis 
Toru Shizuma, Chiharu Tanaka, Hidezo Mori and Naoto Fukuyama 
Department of Physiology, School of Medicine, Tokai University, 
Japan 
1. Introduction  
Kurozu is a traditional Japanese black vinegar that is used in the preparation of foods. It is 
manufactured, mainly in Kagoshima prefecture in Japan, by fermentation of unpolished rice 
with lactobacillus and Koji bacillus in earthenware jars for more than one year, during which 
time it gradually becomes black. The supernatant is known as Kurozu, and the solid 
sediment, which is rich in organic materials, minerals, amino acids and so on, is known as 
Kurozu Moromimatsu (Kurozu-M). Many products containing Kurozu and Kurozu-M are 
available in Japan as health foods or supplements.  
As reported by Murooka et al. (Murooka Y & Yamashita M, 2008), Kurozu has ameliorating 
effects on hyperlipemia and hypertension, as well as anti-cancer activity against colon 
cancer in vitro and in vivo (Nanda K et al., 2004; Shimoji Y et al., 2003; Shimoji Y et al., 2004). 
Further, we reported that Kurozu-M treatment reduced the activity of gelatinases 
(metalloproteinase-2, -9) in tumor tissues, inhibited the growth of human colon cancer cells, 
LoVo, in an animal model (Fukuyama N et al., 2007), and inhibited the growth of 
hepatocellular carcinoma in a diethylnitrosamine-induced animal model (Shizuma T et al., 
2011). Kurozu has also been reported to have free radical-scavenging activity (Murooka Y & 
Yamashita M, 2008). Since active oxygen species or radicals are related to inflammation and 
tissue injury, Kurozu and Kurozu-M may be potential functional foods with preventive or 
therapeutic effects against inflammatory diseases. 
Ulcerative colitis (UC) is an obstinate inflammatory bowel disease (IBD). The causes of UC 
are not well-established, but multiple genetic factors (van Lierop et al., 2009), immune 
responses of the colon (Hong SK et al., 2010) intestinal flora, and inflammatory cytokines 
(Polińska B et al., 2009; Ghosh N et al., 2010) have been suggested to be involved. Moreover, 
oxidative stress is thought to influence the severity of UC (Beckman JS et al., 1990; Babbs CF, 
1992; Grudziński IP & Frankiewicz-Jóźko A, 2001; Hong SK et al., 2010). Enhanced release of 
reactive oxygen species (ROS), such as superoxide and hydroxyl radical, and reactive 
nitrogen species (RNS), such as peroxynitrite generated from nitric oxide (NO), is associated 
with aggravation of both clinical UC and dextran sulfate sodium (DSS)-induced colitis in an 
animal model (Elson CO et al., 1995). 
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Therefore, we decided to examine the protective effects of Kurozu and Kurozu-M in a rodent 
model of DSS-induced colitis, focusing on the possible role of anti-oxidative and anti-
nitration effects. 
2. Main body 
2.1 Materials and methods 
The experimental procedures were approved by the Animal Experimentation Committee, 
School of Medicine, Tokai University, Japan. 
2.1.1 Experimental model 
A solution of 3.5% DSS was given orally for 12 days to forty C57black6 female mice (CLEA 
Japan Inc., Tokyo, Japan). The mice were divided into 4 groups: the control group received 
the standard CE-2 rodent diet (CLEA Japan Inc., Tokyo, Japan) (n=10), the Kurozu group 
received CE-2 diet containing 3.2% solution of Kurozu (n=10), the Kurozu-M group received 
CE-2 diet including 2% Kurozu-M (n=10), and the acetic acid group received CE-2 diet 
including 0.3% solution of acetic acid (n=10). The amounts of Kurozu, Kurozu-M and acetic 
acid were based on volumes typically ingested by humans, adjusted for body weight. All 
mice were bred under specific pathogen-free conditions, because clinical UC is influenced 
by intestinal flora. CE-2 is a standard rodent diet, and includes soybean or white fish meal as 
source of protein, soybean oil or germ as source of lipids, rice bran or alfalfa as a source of 
carbohydrate, vegetable fiber, several vitamins, and minerals. 
The three rodent diets other than the standard CE-2 diet were supplied by Sakamoto 
Kurozu Inc. (Kagoshima, Japan). The standard CE-2 and the three special diets were started 
a week before the initiation of oral DSS administration.  
2.1.2 Experimental procedures 
After initial DSS administration, changes of body weight and bloody stool frequency were 
monitored every 2 days for 12 days in all mice. Then, the mice were sacrificed and the 
proximal colon was resected. Microscopic examination (hematoxylin-eosin (H.E.) staining) 
was performed in all groups, and myeloperoxidase (MPO) staining, as a marker of leukocyte 
activation, was performed for all groups except the acetic acid group. Moreover, histological 
findings in the colon were evaluated and scored in the 4 groups according to the reported 
grading system (Tomita T et al., 2008), as follows. Mucosal damage: 0, normal; 1, 3–10 
intraepithelial cells (IEL)/high power field (HPF) and focal damage; 2, >10 IEL/HPF and 
rare crypt abscesses; 3, >10 IEL/HPF, multiple crypt abscesses and erosion/ulceration. 
Submucosal damage: 0, normal or widely scattered leukocytes; 1, focal aggregates of 
leukocytes; 2, diffuse leukocyte infiltration with expansion of submucosa; 3, diffuse 
leukocyte infiltration. Muscularis damage: 0, normal or widely scattered leukocytes; 1, 
widely scattered leukocyte aggregates between muscle layers; 2, leukocyte infiltration with 
focal effacement of the muscularis; 3, extensive leukocyte infiltration with transmural 
effacement of the muscularis. 
Moreover, enzyme-linked immunosorbent assay (ELISA) of serum tumor necrosis factor 
(TNF)-α and interleukin (IL)-2 as pro-inflammatory cytokines was carried out in the control 
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and Kurozu groups. ELISA measurement of nitrotyrosine levels of resected colonic tissues at 
12 days after initial DSS administration, as a marker of oxidative or nitration stress, was 
performed in all groups except the acetic acid group. Moreover, urinary excretion/day 
(during 11-12 days after initial DSS administration) of nitrite and nitrate (NOx) as a 
parameter of the bioavailability of NO was measured by means of the Griess method (Griess 
reagent kit; Invitrogen Japan K.K, Tokyo, Japan) in the (DSS-induced) control group, the 
Kurozu group, and the group given standard CE-2 diet without administration of DSS (each 
group: n=10). 
2.1.3 Statistical analysis 
The significance of differences of body weight, serum cytokines (TNF-α and IL-2), 
histological scores, and nitrotyrosine and NOx levels among the groups was examined by 
one-way analysis of variance (ANOVA) and Tukey’s multiple comparison post-hoc test. The 
significance of differences in bloody stool frequency was examined by contingency table 
analysis. The criterion of significance was p<0.05.  
Body weight after DSS administration is given as a percentage of basal body weight before 
DSS administration, taken as 100%. Levels of serum cytokines (TNF-α and IL-2) and 
histological scores, nitrotyrosine in colonic tissues, and NOx in urine, are presented as mean 
and standard deviation (SD). The frequency of mice with bloody stool after DSS 
administration is given as a percentage of the number of animals in each group. 
2.2 Results  
2.2.1 Change of body weight 
There were no significant differences of diet or water intake among the four groups 
throughout the 12 days (data not shown). 
The Kurozu group showed a significantly reduced body weight loss in the period of 6-12 
days after initial DSS administration compared with the control group (p<0.001) and in the 
period of 8-12 days after initial DSS administration compared with the acetic acid group 
(p<0.001). The Kurozu-M group showed a significantly reduced body weight loss in the 
period of 6-8 days after initial DSS administration compared with the control group (p<0.05) 
and at 8 and 12 days after initial DSS administration compared with the acetic acid group 
(p<0.05). The acetic acid group showed a significantly reduced body weight loss only at 6 
days after initial DSS administration compared with the control group (p<0.01). The results 
are summarized in Table 1. 
2.2.2 Frequency of bloody stool 
The appearance of bloody stool was noted in all mice of the control and acetic acid groups in 
the period of 4-12 days after initial DSS administration. In contrast, bloody stool was rarely 
noted in the Kurozu group: the frequency was 0% (0/10) during 2-8 days after initial DSS 
administration and only 20% (2/10) at 12 days after initial DSS administration. Similarly, in 
the Kurozu-M group, bloody stool was not noted during 2-8 days after initial DSS 
administration and the frequency was only 30% (3/10) at 12 days (Table 2).  
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Body weight after DSS administration is given as a percentage of the basal body weight before DSS 
administration, taken as 100% (mean SD). (Shizuma T et al., 2011) 
Table 1. Changes of body weight after initial adminsitration of DSS 
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*p<0.01; †days after initial administration of DSS 
The bloody stool frequency in mice after initial DSS administration is given as a percentage of the 
number of animals in each group. (Shizuma T et al., 2011) 
Table 2. Frequencies of bloody stool after initial administration of DSS 
2.2.3 Histology 
H.E. staining revealed epithelial abrasions, cryptal disturbance, hemorrhage and 
inflammatory cell invasion, and thickening of layers in the mucosa and submucosa of the 
colon in the control group, but these changes were minimal in the Kurozu and Kurozu-M 
groups. There was no marked difference between the control group and the acetic acid 
group (Fig.1a~d). Moreover, the Kurozu and the Kurozu-M groups showed fewer MPO-
positive cells than the control group (Fig. 2a~c). 
Histological scores (Tomita T et al., 2008) were as follows: control group, 5.88±0.33; Kurozu 
group, 0.50±0.50; Kurozu-M group, 0.88±0.33; acetic acid group, 4.38±0.48. In the Kurozu 
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group and Kurozu-M groups, the scores were significantly (p<0.001) reduced compared with 
the control and acetic acid groups. Moreover, there was no significant difference between 
the control group and acetic acid group.  
 
(a) control group 
 
 
(b) Kurozu group 
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(c) Kurozu-M group 
 
(d) acetic acid group 
H.E. staining of resected colon revealed abrasions of epithelium, cryptal disturbance, and inflammatory 
cell infitration in mucosa and submucosal areas of colon in the control group. Kurozu and Kurozu-M 
treatment remarkably attenuated these changes in comparison to the control group. The acetic acid 
group showed no marked attenuation of colitis compared with the control group (a, the control group; 
b, the Kurozu group; c, the Kurozu-M group; d, the acetic acid group). 
Fig. 1 Histological findings of resected colon 
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(a) Control group 
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(b) Kurozu group 
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(c) Kurozu-M group 
 
 
 
 
 
 
MPO-positive cells are indicated by θ and ι (a, control group; b, Kurozu group; c, Kurozu-M group). The 
Kurozu and the Kurozu-M groups showed fewer MPO-positive cells than the control group.  
Fig. 2. MPO staining in colonic tissuse 
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2.2.4 Levels of cytokines 
The levels of TNF-α (pg/ml) were 17.2±3.25 in the control group with administration of DSS 
and 15.9±5.77 in the Kurozu group (normal range: 0.6~2.8). Levels of IL-2 (U/ml) were 
1.23±0.37 in the control group with administration of DSS and 1.13±0.39 in the Kurozu group 
(normal range: below 0.8). There were no significant differences in the levels of either of the 
cytokines between the two groups. 
2.2.5 Level of nitrotyrosine in colonic tissue  
The Kurozu group showed a significantly reduced nitrotyrosine level (53.1±7.1 ng/g protein) 
in resected colonic tissue compared with the control group (86.9±11.7 ng/g protein, 
p<0.001). However, the difference from the control was not significant in the Kurozu-M 
group (74.2±15.1 ng/g protein) (Fig. 3).  
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Kurozu treatment significantly (p<0.001) reduced the nitrotyrosine level in resected colonic tissue, in 
comparison to the control group. On the other hand, the difference from the control was not significant 
in the Kurozu-M group. 
Fig. 3. Nitrotyrosine levels in resected colonic tissue 
2.2.6 Level of NOx in urine 
NOx levels in urine (μM) in the (DSS-induced) control group (807±172) and the Kurozu 
group (723±196) were significantly increased compared with the group that did not receive 
DSS administration (517±87). However, there were no significant difference between the 
(DSS-induced) control group and the Kurozu group (Fig. 4). 
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NOx levels in urine (μM) in the (DSS-induced) control group and the Kurozu group were significantly 
increased compared with the control group without DSS administration. However, there was no 
significant difference between the (DSS-induced) control group and the Kurozu group. 
Fig. 4. NOx levels among the three groups 
2.3 Discussion  
Our results indicate that Kurozu and Kurozu-M exert protective effects against DSS-
induced colitis in mice. Kurozu and Kurozu-M both reduced the bloody stool frequency 
and attenuated inflammatory changes of colon tissue, as well as inhibiting body weight 
loss.  
Further, Kurozu and Kurozu-M decreased the number of MPO-positive cells. Since MPO is a 
marker of activation of leukocytes (Schindhelm RK., 2009), both Kurozu and Kurozu-M 
treatments appear to have anti-inflammatory effects in our model. Moreover, Kurozu, but 
not Kurozu-M, significantly reduced the nitrotyrosine level in colonic tissues in comparison 
with the control, although there was no significant difference in NOx level between the 
control and Kurozu groups. Nitrotyrosine is produced via at least two pathways, reaction of 
superoxide and NO, and reaction of nitrite and MPO (Beckman JS et al., 1990; Radi R, 2009). 
Therefore, Kurozu may suppress either of these pathways, or both. On the other hand, NOx 
is a good index of generation of NO by NO synthase (NOS) (Akuta T et al., 2006; Yang GY et 
al., 2009). Since no significant reduction of NOx level by Kurozu treatment was found in this 
study, suppression of NO and nitrite formation can be ruled out as a mechanism of 
reduction of nitrotyrosine generation. Therefore, Kurozu may reduce nitrotyrosine formation 
by suppressing the generation of superoxide or the activity of MPO. 
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In inflammatory states, including UC, generation of superoxide and NO is generally 
accelerated (Cross RK & Wilson KT, 2003). Superoxide itself is cytotoxic and is associated 
with tissue damage in many diseases. Moreover, superoxide and NO rapidly react with each 
other to form highly reactive peroxynitrite, leading to severe tissue damage via nitration of 
protein tyrosine residues to form nitrotyrosine, which is consequently considered to be a 
marker of oxidative and nitration stress. Therefore, peroxynitrite may have played a key 
role in the induction of colitis in this study. 
Regarding the MPO pathway, MPO is mainly released from activated neutrophils. Since it is 
possible that Kurozu may block MPO release from neutrophils in the colonic tissues, we can 
not rule out the possibility that Kurozu suppresses the reaction of MPO and nitrite, thereby 
leading to a reduction of nitrotyrosine formation. However, Kurozu-M treatment did not 
reduce the generation of nitrotyrosine significantly, although infiltration of MPO-positive 
cells was remarkably suppressed. Moreover, the cytotoxity of MPO itself is unclear; our 
previous study demonstrated that MPO was protective against tissue injury in MPO knock-
out mice, although in that case, we examined brain tissue (Takizawa S et al., 2002). 
However, at present, we have no evidence that the reduction of nitrotyrosine level in the 
Kurozu group involves suppression of MPO. Rather, our findings indicate that the 
mechanism predominantly mediating the anti-colitis effect of Kurozu is suppression of 
superoxide production, leading to decreased generation of peroxynitrite, which is strongly 
cytotoxic, or other ROS and RNS, although at this stage we can not rule out the possibility 
that suppression of MPO also contributes.  
Overall, our results indicate that Kurozu and Kurozu-M both have an anti-colitis effect in the 
DSS-induced mouse colitis model, though Kurozu is more potent. This, in turn, suggests that 
the active materials are predominantly soluble compounds, because Kurozu-M is the 
precipitate formed during the manufacture of Kurozu.  
Kurozu contains acetic acid, free amino acids, peptides, minerals, water-soluble vitamins, 
organic compounds including bacterial fermentation products, lipids and saccharides. Its 
main component is acetic acid, but we found here that acetic acid did not affect body weight 
loss, bloody stool frequency, or pathological findings in DSS-induced mice, compared with 
the control. Further, acetic acid is not present in Kurozu-M. Therefore, acetic acid is not one 
of the major protective components against colitis. 
Amino acids seem to be good candidates for the anti-colitis agents in Kurozu and Kurozu-M. 
For example, glutamine has a protective effect on gut function, and has been suggested to 
have an anti-colitis effect in an animal model (Ameho CK et al., 1997). Other amino acids or 
their metabolites or degradation products, including arginine, asparagine, cysteine, serine 
(Faure M et al., 2006), methionine, and tryptophan, are known to have anti-oxidative effects 
(Wu G, 2009). Moreover, cysteine (Kim CJ et al., 2009), serine and tryptophan (Kim CJ et al., 
2010) were found to have protective effects in animal models of colitis. Therefore, free amino 
acids or peptides may be among the active agents present in Kurozu and Kurozu-M. 
Other organic materials, including lactic acid and products of lactobacillus or Koji bacillus 
fermentation, are also candidate protective agents. Kurozu is fermented with lactobacillus or 
Koji bacillus for several years in earthenware jars, and lactobacillus is well known as a 
beneficial component of human intestinal flora. Moreover, clinically significant anti-colitis 
effects of administration of probiotics (Sartor RB, 2004) or synbiotics (Kanauchi O et al., 
www.intechopen.com
Protective Effects of Japanese Black Vinegar “Kurozu” 
and Its Sediment “Kurozu Moromimatsu” on Dextran Sulfate Sodium-induced Experimental Colitis 
 
173 
2009) have been reported in patients with mild UC. Further, anti-oxidative effects and 
protective effects against animal colitis were reported for Koji bacillus (Fukuda Y et al., 
2006;Lee IH et al.,2008). Therefore, many components of Kurozu and Kurozu-M, including 
amino acids and oligopeptides, as well as other organic materials, may contribute to the 
anti-colitis effects observed here. 
At present, UC is generally treated with anti-inflammatory agents, such as 5-aminosalicylic 
acid (5-ASA) and prednisolone (Rogler G, 2009). However, administration of these drugs is 
sometimes accompanied with severe side effects. Therefore, a dietary therapy would be 
desirable, particularly from the viewpoints of safety and long-term effectiveness.  
In order to further examine the mechanism of action of Kurozu, additional study will be 
needed to evaluate the quantitative changes of pro-inflammatory cytokines in resected 
colonic tissues, for example, measurement of mRNA expression levels in tissues of the DSS-
induced control and Kurozu groups, because there was no difference in the serum levels of 
pro-inflammatory cytokines. It could not be determined in this study whether Kurozu has a 
direct anti-oxidant effect, because the absorption, distribution, metabolism and excretion 
characteristics of Kurozu and its constituents in the mouse remain to be determined. This 
question might be addressed by means of in vitro experiments on colonic cell lines or rectal 
application of Kurozu in an animal model. 
For the practical use of Kurozu in the management of colitis patients, it will be necessary 
to identify optimum dosages and administration schedules. Many products containing 
Kurozu are available in Japan as health foods or supplements, and in this study, the 
amounts of Kurozu used were based on volumes typically ingested by humans, adjusted 
for body weight. The next step will be a clinical trial to examine the anti-colitis effects of 
Kurozu as an oral supplement in patients with mild ulcerative colitis, focusing initially on 
typical dose and administration schedules recommended for existing health foods and 
supplements. 
3. Conclusion 
Our results indicate that Kurozu exerts a protective effect against DSS-induced colitis in 
mice, and one of the mechanisms involved may be an anti-oxidative or anti-nitration stress 
activity. 
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